Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 30, 2022 - Issue 7-8
Submit an article Journal homepage
148
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Late-onset Etanercept-associated Ocular Sarcoidosis with Profound Vision Loss

Murtaza Saifeea Department of Ophthalmology, University of California, San Francisco, California, U.S.AView further author information
, MD,
Alok Bansalb Northern California Retina Vitreous Associates, Daly City, California, U.S.AView further author information
, MD,
Gregory J. Bevera Department of Ophthalmology, University of California, San Francisco, California, U.S.AView further author information
, MD &
Jay M. Stewarta Department of Ophthalmology, University of California, San Francisco, California, U.S.ACorrespondence[email protected]
View further author information
, MD
Pages 2055-2059 | Received 08 Mar 2021, Accepted 24 Jul 2021, Published online: 04 Aug 2021

References

  • Wakefield D, Zierhut M. Controversy: ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18(1):5–9. doi:10.3109/09273941003597276.
  • Herbort CP, Rao NA, Mochizuki M; the members of the Scientific Committee of the First International Workshop on Ocular Sarcoidosis (IWOS). International criteria for the diagnosis of ocular sarcoidosis: results of the First International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–169. doi:10.1080/09273940902818861.
  • Acharya NR, Browne EN, Rao N, Mochizuki M. Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology. 2018;125(1):119–126. doi:10.1016/j.ophtha.2017.07.006.
  • Takase H, Shimizu K, Yamada Y, Hanada A, Takahashi H, Mochizuki M. Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis. Jpn J Ophthalmol. 2010;54(6):529–536. doi:10.1007/s10384-010-0873-2.
  • Dragnev D, Barr D, Kulshrestha M, Shanmugalingam S. Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab. Case Rep. 2013;2013(sep04 1):bcr2013200552–bcr2013200552. doi:10.1136/bcr-2013-200552.
  • Fonollosa A, Artaraz J, Les I, et al. Sarcoid intermediate uveitis following etanercept treatment: a case report and review of the literature. Ocul Immunol Inflamm. 2012;20(1):44–48. doi:10.3109/09273948.2011.623212.
  • Skoie IM, Wildhagen K, Omdal R. Development of sarcoidosis following etanercept treatment: a report of three cases. Rheumatol Int. 2012;32(4):1049–1053. doi:10.1007/s00296-009-1349-x.
  • Hashkes PJ, Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol. 2003;21:645–646.
  • Daien CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology. 2009;48(8):883–886. doi:10.1093/rheumatology/kep046.
  • Suzuki J, Goto H. Uveitis associated with sarcoidosis exacerbated by etanercept therapy. Jpn J Ophthalmol. 2009;53(4):439–440. doi:10.1007/s10384-009-0691-6.
  • Louie GH, Chitkara P, Ward MM. Relapse of sarcoidosis upon treatment with etanercept. Ann Rheum Dis. 2008;67(6):896–898. doi:10.1136/ard.2007.078840.
  • Sobolewska B, Baglivo E, Edwards AO, et al. Drug-induced sarcoid uveitis with biologics. Ocul Immunol Inflamm. February 17, 2021;1–8. Published online. doi:10.1080/09273948.2020.1850799.
  • Amber KT, Bloom R, Mrowietz U, Hertl M. TNF-α: a treatment target or cause of sarcoidosis? J Eur Acad Dermatol Venereol. 2015;29(11):2104–2111. doi:10.1111/jdv.13246.
  • Wallis RS, Ehlers S. Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum. 2005;34(5):34–38. doi:10.1016/j.semarthrit.2005.01.009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.